The US-based Duke University psychology and behavioural economics professor won't publicly reveal the Fortune 500 companies he advises, but is reportedly often called upon by high-profile business executives for his insights.
It took nearly 10 years for Tribeca Investment Partners to regain its independence. But since buying back the firm in August the founders have wasted no time. A $250 million listed investment company focused on resources was raised in October and there are now plans for a new international fund focused on the rise of the Asian consumer.
Hold your nerve. The trends of software infiltrating every industry, and every company becoming a tech company - are only just beginning. That is the message top fund managers have for investors this, as big name tech stocks tumbled amid a broader market rout.
When Leah Zell, one of the world's most highly regarded international small cap investors, took the stage at the Sohn Hearts and Minds conference in Sydney two years ago, she memorably presented a Turkish supermarket, BIM, as one of the best ideas in her universe.
Enterprise software companies such as Australian trailblazer Atlassian will increasing replace consumer-focused technology firms as the hottest tech stocks of the future, according to a leading New York fund manager.
It may be one of the fastest boutique fund management builds seen in Australia. Long-short manager Firetrail Investments announced this week that it is already profitable, just over six months since opening its doors. And by the close of the September quarter next week it expects to announce the funds under management have “comfortably passed” $2 billion.
Star American philanthropist Michael Milken has urged Australians not to fear the rise of Amazon but be inspired by the unprecedented ability to view everyone in the world as a potential customer because of the digital technology revolution.
The rapid rise of personalised medicine and associated better pricing for health insurance cover flowing from cutting-edge technologies such as genomics will provide exciting new investment opportunities, according to one of the nation’s top global equities managers.
The Australian public will get the opportunity to bankroll the best investment ideas from leading local and international fund managers while supporting medical research, in a new $100 million listed investment company.
Star American philanthropist Michael Milken will make his first visit to Australia in almost a decade next month as part of a fresh push by the leaders of the annual Sohn Hearts & Minds investment conference to increase corporate support for medical research.